Formulation of a stable and high-loaded quercetin injectable emulsion

Pharmaceutical Development and Technology

Volumn 16, Issue 6, 2011, Pages 609-615

  Sun, Huizhu ^a   Xu, Heming ^a   Yang, Xinggang ^a   Li, Nan ^b   Liu, Zhidong ^b   Pan, Weisan ^a   Yuan, Yue ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Emulsion; High loaded; Quercetin phospholipids complex; Solutol HS 15; Stability

Indexed keywords

ALPHA TOCOPHEROL; CREMOPHOR; DICHLOROMETHANE; GLYCEROL; MIGLYOL; OLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; QUERCETIN; SODIUM CHLORIDE; SOLUTOL HS 15; SOYBEAN OIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG QUALITY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STERILITY; DRUG STORAGE; EAR; EMULSION; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; INFRARED SPECTROSCOPY; INJECTION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPE; SURFACE PROPERTY; TEMPERATURE; TEMPERATURE STRESS; TRANSMISSION ELECTRON MICROSCOPY; VEIN;

ANIMALS; ANTIOXIDANTS; DRUG STABILITY; DRUG STORAGE; EMULSIONS; EXCIPIENTS; INJECTIONS, INTRAVENOUS; LECITHINS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; QUERCETIN; RABBITS; SOYBEANS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STERILIZATION; TIME FACTORS; TOXICITY TESTS;

EID: 80755181428     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.502899     Document Type: Article

References (20)

1. Hollman PC, Kata MB. Dietary favonoids: Intake, health efects and bioavailability. Food Chem Toxicol 1999;37(9-10):937-942. (Pubitemid 29481795)
2. Khaled KA, El-Sayed YM, Al-Hadiya BM. Disposition of the favonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 2003;29(4):397-403. (Pubitemid 36528607)
3. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975;9(2-3):229-234.
4. Tamilvanan S. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Prog Lipid Res 2004;43(6):489-533. (Pubitemid 39441344)
5. Nasirideen S, Kas HS, Oner F, Alpar R, Hincal AA. Naproxen incorporated lipid emulsion. I. Fomulation and stability studies [J]. J Clin Pharm Ter 1998;23(1):57-65. (Pubitemid 28380376)
6. Scalia S, Mezzena M. Incorporation of quercetin in lipid microparticles: Efect on photo-and chemical-stability. J Pharm Biomed Anal 2009;49(1):90-94.
7. Yong DQ, Xi YW, Zhai GX. Study on the physico-chemical properties of quercetin-phospholipid complex. Chin J Bio Pharm 2005;26(5):285-287.
8. Bombardelli E, Patri GF. Complex compounds of biofavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them. U.S. Patent 5,043,323; 1991.
9. Lu Y, Zhang Y, Yang Z, Tang X. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats. Int J Pharm 2009;366(1-2):160-169.
10. Wang Y, Mesfn GM, Rodriguez CA, Slatter JG, Schuette MR, Cory AL, et al. Venous irritation, pharmacokinetics, and tissuedistribution of tirilazad in rats following intravenous administration of anovel supersaturated submicron lipid emulsion [J]. Pharm Res 1999;16(6):930-938. (Pubitemid 29284207)
11. Zhang HY, Tang X, Li HY, Liu XL. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics. Int J Pharm 2008;348(1-2):70-79. (Pubitemid 350266241)
12. Jumaa M, Muller BW. Development of a novel parenteral formulation for tetrazepam using a lipid emulsion. Drug Dev Ind Pharm 2001;27(10):1115-1121. (Pubitemid 34053207)
13. Jumaa M, Muller BW. Te efect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharm 1998;163:81-89. (Pubitemid 28162622)
14. Driscoll DF, Bacon MN, Bistrian BR. Physicochemical stability of two diferent types of intravenous lipid emulsion as total nutrient admixtures. J Parenter Enteral Nutr 2000;24(1):15-22. (Pubitemid 30027149)
15. Jeppsson RI, Groves MJ, Yalabik HS. Te particle size distribution of emulsions containing diazepam for intravenous use. J Clin Pharm 1976;1:123-127.
16. Ruchatz F, Schuch H. Physicochemical properties of solutol HS 15 and its solubisates. BASF ExAct 1998;1:6-7.
17. Rajebahadur M, Zia H, Nues A, Lee C. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS 15. Drug Deliv 2006;13(3):201-206.
18. Bittner B, Gonzalez RC, Walter I, Kapps M, Huwyler J. Impact of solutol HS 15 on the pharmacokinetic behavior of colchicine upon intravenous administration to male Wistar rats [J]. Biopharm Drug Dispos 2003;24(4):173-181. (Pubitemid 36656391)
19. Buszello K, Harnisch S, Muller RH, Muller BW. Te infuence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modifed with Solutol HS 15. Eur J Pharm Biopharm 2000;49(2):143-149. (Pubitemid 30126062)
20. Eastoe J, Hetherington KJ, Sharpe D, Dong J. Mixing of alkanes with surfactant monolayers in microemulsions [J]. Langmuir 12. 1996; 3876-3880. (Pubitemid 126531351)